Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome

Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome

The endocannabinoidome (expanded endocannabinoid system, eCBome)-gut microbiome (mBIome) axis plays a fundamental role in the control of energy intake and processing. The liver-expressed antimicrobial peptide 2 (LEAP2) is a recently identified molecule acting as an antagonist of the ghrelin receptor...

Full description

Bibliographic Details
Main Authors: Mélissa Shen, Claudia Manca, Francesco Suriano, Nayudu Nallabelli, Florent Pechereau, Bénédicte Allam-Ndoul, Fabio Arturo Iannotti, Nicolas Flamand, Alain Veilleux, Patrice D. Cani, Cristoforo Silvestri, Vincenzo Di Marzo
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Molecules
Subjects:
endocannabinoid
PPARs
gut microbiome
intestine
ghrelin
LEAP2
Online Access:https://www.mdpi.com/1420-3049/27/1/1

Internet

https://www.mdpi.com/1420-3049/27/1/1

Similar Items